Scientific Programme

EPA leadership and congress organisers are working together to build an exciting congress programme with an adapted format mindful of the current context.

Sign up for the congress newsletter to receive the latest updates about EPA 2022, including scientific programme announcements, registration rates, e-poster information, deadline reminders, and more.

Click on the button below to view the EPA 2022 Scientific Programme.

Interactive Programme

*The programme is subject to change. Updated 14 April 2022.

Core Programme

Click on the session names below to view more information.

Implementing Alternatives to Coercion in Mental Health Care

Session Chair: Prof. Philip Gorwood, France
Speaker: Prof. Silvana Galderisi, Italy

Print Friendly, PDF & Email

Psychedelic Psychiatry

Session Chair: Prof. Geert Dom, Belgium
Speaker: Prof. David Nutt, UK

Print Friendly, PDF & Email

Inclusive Perspectives of Reforms in Psychiatry: What did we Achieve and What Needs to be Done?

Session Chair: Prof. Peter Falkai, Germany
Speaker: Prof. Andreas Heinz, Germany

Print Friendly, PDF & Email

Free Sales of Cannabis Should be Made Legal

Session Chair: Prof. Geert Dom, Belgium

Pro
Speaker: TBC

Con
Speaker: Prof. Michael Krausz, Canada

Print Friendly, PDF & Email

Do Clinicians Need to Rethink Antipsychotic Maintenance Treatment?

Session Chair: Dr. Jan Wise, UK

Pro
Speaker: Prof. John Kane, US

Con
Speaker: Prof. Wim Veling, The Netherlands

Print Friendly, PDF & Email

Has Clinical Translation of Scientific Research been a Failure?

Session Chair: Prof. Peter Falkai

Pro
Speaker: Prof. Elisabeth Binder, Austria

Con
Speaker: Prof. Anthony David, UK

Print Friendly, PDF & Email

Psychiatric Symptoms of Long-Covid Syndrome: Pathophysiology and Treatment Options

Session Chair: Prof. Jerzy Samochowiec, Poland
Speaker: Dr. Marco Solmi, Italy

Print Friendly, PDF & Email

Digital Mental Health: Towards Personalised Care in Psychiatry

Session Chair: Prof. Umberto Volpe, Italy
Speaker: Prof. Inez Myin-Germeys, Belgium

Print Friendly, PDF & Email

Transcultural Aspect of Mental Health Care

Session Chair: Prof. Lars Lien, Norway
Speaker: Prof. Meryam Schouler-Ocak, Germany

Print Friendly, PDF & Email

A Once Malignant Malady: the Story of Schizophrenia and the Path to Prevention

Session Chair: Prof. Tamás Kurimay, Hungary
Speaker: Prof. Jeffrey Lieberman, USA

Print Friendly, PDF & Email

Early Intervention Programmes in Psychosis

Session Chair: Dr. Martina Rojnić-Kuzman ,Croatia
Speaker: Prof. Merete Nordentoft, Denmark

Print Friendly, PDF & Email

45 Years of Research on Psychotherapy for Depression: Lessons for the Future

Session Chair: Dr. Julian Beezhold, UK
Speaker: Prof. Pim Cuijpers, Netherlands

Print Friendly, PDF & Email

Current Innovations in Psychopharmacology

Session Chair: Prof. Philip Gorwood, France
Speaker: Prof. Christoph Correll, USA

Print Friendly, PDF & Email

Sleep and Mental Disorders

Session Chair: Prof. Peter Falkai, Germany
Speaker: Prof. Thomas Pollmächer, Germany

Print Friendly, PDF & Email

OCD: New Breakthroughs

Session Chairs:
Dr. Cécile Hanon, France
Prof. Diego Palao Vidal, Spain

Improving OCD by Modulating Brain Circuits
Speaker: Dr. José Manuel Menchón, Spain

Feasibility and Acceptability of Transcranial Direct Current Stimulation in Obsessive Compulsive Disorder
Speaker: Prof. Naomi Finerberg, UK

The Latest Results of the ENIGMA-OCD Consortium: an Example of Powerful Worldwide Collaboration on Brain Imaging

Speaker: Prof. Odile van den Heuvel, The Netherlands

Deep Brain Stimulation in Patients with Severe Resistant OCD: 10 Years of Experience in Barcelona
Speaker: Dr. María del Pino Alonso Ortega, Spain

Print Friendly, PDF & Email

Impact of the COVID-19 Pandemic on Youth Mental Health

Session Chairs:
Prof. Andrea Fiorillo, Italy
Dr. Ozge Kilic, Turkey

Has Suicide Really Increased After the COVID-19 Pandemic?
Speaker: Prof. Danuta Wasserman, Sweden

Stress, Resilience and Psychiatric Morbidity in Youth at the Time of COVID-19
Speaker: Prof. Andrea Fiorillo, Italy

Increase in the Use of Alcohol and Other Substances in Adolescents During and After the COVID-19 Pandemic
Speaker: Prof. Geert Dom, Belgium

The Effects of the COVID-19 Pandemic on Mother-Infant Mental Health Relationship
Speaker: Prof. Judit Balázs, Hungary

Print Friendly, PDF & Email

The Impact of Racism and Discrimination on Mental Health of Ethnic Minorities

Session Chairs:
Prof. Meryam Schouler-Ocak, Germany

The Impact of Racism and Discrimination on the Mental Health of Refugees and Asylum Seekers
Speaker: Dr. Marianne Kastrup, Denmark

Racism, Discrimination, Otherism and Tribalism and Mental Health
Speaker: Prof. Dinesh Bhugra, UK

What do Health/Mental Health Professionals Have to do With Racial Discrimination?
Speaker: Dr. Levent Küey, Turkey

Multiple Discrimination and Its Consequences for the Mental Health of Ethnic Minorities
Speaker: Prof. Meryam Schouler-Ocak, Germany

Print Friendly, PDF & Email

Benefits and Goals of a Human Rights-Based Approach (HRBA) to Mental Health Care

Session Chairs:
Prof. Simavi Vahip, Turkey
Mr. Andre Decraene, Belgium

A Human Rights-Based Approach To Acute Mental Health Crisis Care
Speaker: Dr. Lieselotte Mahler, Germany

The Evidence Base For Psychiatric Support For Living Independently And Being Included In The Community
Speaker: Prof. Armida Mucci, Italy

Human Rights And Clinical Practice In The Treatment Of The Most Vulnerable
Speaker: Prof. Michael Krausz, Canada

Family and Service User Involvement in the implementation of a human rights-based approach to mental health care
Speaker: Ms. Katerina Nomidou, Greece

Print Friendly, PDF & Email

At the Heart of Eating Disorders: The Progress of Assessments Clinicians Should Know for Optimal Treatment and Clearer Prognosis

Session Chairs:
Prof. Philip Gorwood, France
Dr. Livia De Picker, Belgium

Continuous Glycaemia and Heart Rate Monitoring in Eating Disorders: From New Devices to Clinical Meanings
Speaker: Dr. Philibert Duriez, France

For Neurocognitions
Speaker: Prof. Fernando Fernandez-Aranda, Spain

For Personality Disorders
Speaker: Prof. Janet Treasure, UK

Anorexia Nervosa as a Metabo-Psychiatric Disorder – Consequences for Assessment and Treatment in Childhood and Adolescence.
Speaker: Prof. Beate Herpertz-Dahlmann, Germany

Print Friendly, PDF & Email

Best of 2021: Research that Advanced Psychiatry and Changed our Practice

Session Chairs:
Dr. Jan Wise, UK
Prof. Agata Szulc, Poland

Old Age Psychiatry
Speaker: Prof. Nicolas Hoertel, France

Forensic Psychiatry
Speaker: Prof. Birgit Völlm, Germany

Eating Disorders
Speaker: Prof. Janet Treasure, UK

Print Friendly, PDF & Email

Cannabis: Adolescent Use, Psychiatric Impact and Preventive Work

EPA-EUFAS Joint Symposium

Session Chairs:

Prof. Geert Dom, Belgium

Prof. Colin Drummond, UK

Adolescent Cannabis Use, Cognition, Brain Health and Educational Outcomes: A Review of the Evidence

Speaker: Dr. Valentina Lorenzetti, Germany

Cannabis Induced Psychosis

Speaker: Prof. Jørgen G. Bramness, Norway

Cannabis Related Impact on Subcategories of Psychotic Symptoms

Speaker: Prof. Benjamin Rolland, France

Standard Units for Cannabis Dose: Why is it Important to Standardise Cannabis Dose for Drug Policy and How Can we Enhance its Place on the Public Health Agenda?

Speaker: Prof. Hugo López-Pelayo, Spain

Print Friendly, PDF & Email

On the Transitional Period from Pandemic Times Towards ‘New Normal’: Experiences and Challenges in Different European Countries

EPA NPAs Symposium

Session Chairs:

Prof. Jerzy Samochowiec, Poland

Prof. Simavi Vahip, Turkey

Practicing Psychiatry in the Transitional Period: Lessons Learnt and Issues of the Steps Towards the New Normal

Speaker: Prof Mohammed Al-Uzri, UK

Education and Training in Psychiatry: Challenges and Consequences of the Last Two Years, Future Perspectives and Actions Needed

Speaker: Prof. Koray Başar, Turkey

Impact of the Pandemic on Psychiatric Research and Publications

Speaker: Prof. Pavel Mohr, Czech Republic

Dealing with the Pandemic and After for Children and Adolescents, and their Families

Speaker: Prof. Gisele Apter, France

Print Friendly, PDF & Email

Etiology and Treatment of the Long Covid-19 Syndrome

EPA-EAN Joint Symposium

Session Chairs:

Prof. Peter Falkai, Germany

Prof. Claudio Bassetti, Switzerland

The COVID-19 Infection/Pandemic (General Introduction)

Speaker: Prof. Josef Eberle, Germany

Psychiatric Complications (Including Long-Covid, Diagnosis and Treatment)

Speaker: Dr. Marco Solmi, Canada

Neurological Complications (Including Long-Covid, Diagnosis and Treatment)

Speaker: Prof. Elena Moro, France

Covid-19: Lessons for Mental and Brain Health

Speakers: Prof.Peter Falkai, Germany and Prof. Claudio Bassetti, Switzerland

Print Friendly, PDF & Email

Update on Resilience in Mental Health Diseases and Care Givers

EPA-EFPA Joint Symposium

Session Chairs:

Prof. Philip Gorwood, France

Prof. Christoph Steinebach, Switzerland

Promoting Resilience Through Evidence-based Practice in Cases of Childhood Trauma

Speaker: Dr. Eleni Karayianni, Cyprus

Resilience and Wellbeing in Mental Health Workforce: Why it Matters and How to Develop it

Speaker: Prof. Christoph Steinebach, Switzerland

Resilience Factors Preventing Schizophrenia in Ultra-high Risk Patients: Lessons from Genetics

Speaker: Dr. Boris Chaumette, France

Resilience and Coping Strategies of the General Population during the COVID-19 Pandemic

Speakers: Prof. Andrea Fiorillo, Italy

Print Friendly, PDF & Email

The Emergent Potential of Psychedelics for Treatment of Brain Disorders

ECNP Symposium hosted by the EPA

Session Chairs:

Prof. Kim Kuypers, The Netherlands

Prof. David Nutt, UK

Safety, characterisation, and distinction of serotonergic psychedelics

Speaker: Prof. Friederike Holze, Switzerland

(Sub)acute and longer lasting effects of psychedelics on behaviors and their underlying biology

Speaker: Prof. Kim Kuypers, The Netherlands

Clinical trials with psilocybin in patients with major depression

Speaker: Prof. David Erritzøe, UK

Psychedelics and Emotions

Speakers: Prof. Sophia Armand, Denmark

Print Friendly, PDF & Email

Are Psychedelics Changing the Paradigm of the Treatments of Psychiatric Disorders? A dialogue between neuroscientists and clinicians

EPA-FENS Joint Symposium

Session Chairs:

Prof. Philip Gorwood, France

Prof. Jean-Antoine Girault, France

Restoring Functional Circuits with Psychedelics

Speaker: Prof. David Olson, USA

Brain imaging psychedelic effects in depression

Speaker: Prof. David Nutt, UK

Psychedelics in Mood, Anxiety, and Substance-use Disorders: From Safety to Efficacy

Speaker: TBC

The Impact of Psychedelics on Cognitions and Emotions

Speakers: Prof. Kim Kuypers, The Netherlands

Print Friendly, PDF & Email

Human Rights and Mental Disorders: An Issue Worth Fighting for

EPA-EUFAMI-GAMIAN Joint Symposium

Session Chairs:

Prof. Geert Dom, Belgium

Dr. Julian Beezhold, UK

The Involvement of Families in Mental Health Care – A Human Right!

Speaker: Mr. Andre Decraene, Belgium

Access to mental Health Services During a/the Pandemic: A Human Right?

Speaker: Ms Hilkka Kärkkäinen, Finland

Involuntary care: Abolish or Regulate? UN-CRPD versus European Convention on Human Rights

Speaker: Prof Geert Dom, Belgium

Recovery Oriented Services to Overcome Human Rights Violations in Mental Health Care

Speakers: Prof. Silvana Galderisi, Italy

Print Friendly, PDF & Email

‘Suicide-2022’: An Update Organised by the EPA-host Hungarian Psychiatric Association

Hosting NPA: Hungarian Psychiatric Association

Session Chairs:

Prof. Judit Balasz, Hungary

Prof. Danuta Wasserman, Sweden

Pathways to Suicidal Behaviour

Speaker: Prof. Katalin Szántó, USA

Covid-19 and Suicide in the World

Speaker: Prof. Danuta Wasserman, Sweden

(Nonsuicidal) Self-Injury

Speaker: Prof. Judit Balasz, Hungary

Suicidal Behaviour in Hungary

Speakers: Prof. Zoltán Rihmer, Hungary

Print Friendly, PDF & Email

The Development of Targeted Psychotherapeutic Interventions Addressing Specific Needs in Africa

Symposium for African audience

Session Chairs:

Dr. Michael Odenwald, Germany

Dr. Christine Musyimi, Kenya

Development of a Mobile Phone Based Healthy Anger Management Intervention to Reduce Intimate Partner Violence in Kenya

Speaker: Dr. Christine Musyimi, Kenya

NETfacts – Addressing Trauma and Violence at the Community Level. Experiences from DRC 

Speaker: Dr. Amani Chibashima, Germany

Preventing PTSD in the Aftermath of Childhood Sexual Abuse in Burundi 

Speaker: Dr. Anselm Crombach, Germany

The Effects of Khat Use on Anti-TB Treatment – Ways Forward 

Speakers: Dr. Matiwos Soboka, Germany

Print Friendly, PDF & Email

ECP Programme

EPA 2022 invites recent graduates to its specialist programme tailored to the needs of the Early Career Psychiatrist (ECP).

Click the button below to learn more.

ECP Programme

EPA Educational Courses

The European Congress of Psychiatry will serve the educational mission of the EPA by providing high-quality education courses, covering all aspects of psychiatry. Each course is 3 hours long and will present advanced material on a chosen topic of practical relevance.

Click the button below to view the EPA 2022 selected Courses.

EPA Courses

Session Descriptions

The EPA 2022 scientific programme will cover the latest developments in psychiatry, through state-of-the-art presentations, live moderation, discussions and more. Click below to view detailed descriptions of all the session formats on offer at the EPA Congress.

The European Congress of Psychiatry serves the educational mission of the EPA by providing high-quality EPA Courses, covering all aspects of psychiatry. Fees are charged separately for the courses. Each EPA Course is composed of two 90-minute sessions.

COURSES-690x510

The State-of-the-Art lectures have a strong clinical focus, providing a complete update on significant aspects of current clinical treatments in European psychiatry. The State-of-the-Art lectures are delivered by top European or worldwide experts and last 45 minutes.

state-of-the-art-1-690x510

The Plenary lectures are mainly theoretical and research-oriented, with a strong scientific focus. These lectures are delivered by leading psychiatrists, scientists and other mental health professionals invited by the Scientific Programme Committee. They cover the major topics of the Congress theme.

plenary-1-690x510

Debates offer a lively and fruitful discussion on controversial issues. A chairperson moderates the debate and the following discussion, while two speakers (proponent /opponent) offer and challenge opinions on “hot topics” for 30 minutes each. Participants may also be asked to interact by voting at the beginning and/or end of the session.

debate-690x510

These 90-minute sessions, selected by the Scientific Programme Committee, focus on specific topics in psychiatry, representing several points of view. Each symposium includes four presentations by international speakers and offers an opportunity for discussion at the end.

State-of-the-art-690x510

The Workshops are devoted to a specific topic and bring together experts in this field for an intensive discussion. These are 90-minute working sessions, with 30 minutes devoted to discussion and interactivity.

epa21-sess-descr-workshop

The EPA invites recent graduates to follow its specialist programme, which is tailored to the needs and interests of early career psychiatrists. The ECP Programme is composed of a Networking Evening and a special track of sessions throughout the Congress.

ECL-690x510

Ask the Experts sessions allow participants to meet in a small group with outstanding researchers and clinicians. The format is designed to facilitate informal discussions, allowing participants to present their questions and gain new perspectives. Sessions take place at round tables and are limited to a certain number of participants with advanced sign-up required.

mte-690x510

Authors are invited to submit abstracts, classified by topics. There is a limitation concerning the number of submissions per individual. Submitted abstracts are reviewed by the Scientific Programme Committee and scheduled as Oral Communications, e-Poster Presentations, or e-Poster Viewing.
Those abstracts scoring the highest will be allotted an Oral Communication. The author will have the opportunity to present their research in a dedicated session during the Congress.

All accepted abstracts whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.

workshop-690x510

Authors of abstracts allotted to the second-highest category of scoring are invited to present their research findings or important ongoing research during an e-Poster Presentation, where they have around 3 minutes to present their e-Posters displayed on a digital screen.

All accepted abstracts whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.

epv-690x510

All authors of accepted abstracts will be able to view their poster on the congress website, app and on the digital screens onsite. The e-posters are accessible to all delegates throughout the Congress for individual viewing.

All accepted abstracts whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.

epview-690x510

Satellite Symposia are organised by pharmaceutical companies in consultation with the Scientific Programme Committee. These sessions are fully integrated into the Congress, but are sessions entirely designed, produced and driven by the pharmaceutical industries by an unrestricted educational grant.

sponsession-1-690x510
Print Friendly, PDF & Email